Health Sector Sees Mixed Developments: Resolutions, Delays, and Innovations
The U.S. Food and Drug Administration announced a resolution to the nation’s saline shortage, a move easing…
ETFs in Focus on Eli Lilly’s Solid Q2 Earnings, Weak Obesity Data
Eli Lilly and Company LLY reported robust second-quarter 2025 results, wherein it beat estimates on both the top…
Novo Nordisk’s diabetes and weight loss drug sales growth decelerates
Novo Nordisk saw sales growth for its diabetes and obesity care segment slow in the first half of…
Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.
President Trump’s tariffs could erode healthcare companies’ profits, but some may perform well regardless. Eli Lilly and Novartis…